Skip to main content
. 2021 Dec 21;11:24336. doi: 10.1038/s41598-021-03731-9

Figure 4.

Figure 4

Quantification of differential expression of full-length ACE2 and the short dACE2 isoform in specific structures of human tissues. Graphical output shows the fold change in mean fluorescence observed for the respective secondary antibodies used to visualise ACE2poly and ACE2mono in distinct anatomical structures of the human tissue sections shown in Fig. 3. For each structure, n = 6 from ≥ 2 tissue sections. (a) Fold change in mean fluorescence observed for ACE2poly and ACE2mono in kidney cortex and glomeruli (Glom.), versus the normalised mean fluorescence observed in the renal medulla. (b) Fold change in mean fluorescence observed for ACE2poly and ACE2mono in airway structures and blood vessels (Blood ves.) of the lung, versus the normalised mean fluorescence observed in the connective tissue (Connec.). (c) Fold change in mean fluorescence observed for ACE2poly and ACE2mono in liver bile ducts and blood vessels (Blood ves.), versus the normalised mean fluorescence observed in liver hepatocytes (Hepato.). All data show mean ± SEM with individual data points shown. Statistical analyses of data included a one way ANOVA with multiple comparisons using Tukey’s correction. Statistical significance was determined where p < 0.05. **** or #### = p < 0.0001; ** = p < 0.01; n.s. = no significant difference.